The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
Clinical trial NCT04134091 · COMPLETED
Trial details
- NCT number
- NCT04134091
- Sponsor
- Lipocine Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-27
- Primary completion
- 2021-06-24
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.